Competitive Landscape Analysis of the Middle EAST Cell and Gene Therapy Biomanufacturing CDMO Market
The Middle EAST Cell and Gene Therapy Biomanufacturing CDMO Market was valued at USD 0.75 billion in 2024 and is projected to reach USD 2.50 billion by 2034, registering a CAGR of 13.20%. This growth trajectory is underpinned by the increasing demand for advanced therapies, driven by a rising prevalence of genetic disorders and chronic diseases. The region's strategic investments in healthcare...
0 Комментарии 0 Поделились 0 Отзывы
Реклама
VintFint https://vintfint.com